History of major depressive disorder and endothelial function in postmenopausal women

Psychosomatic Medicine

Volumn 68, Issue 1, 2006, Pages 80-86

  Wagner, Julie A ^a   Tennen, Howard ^a   Mansoor, George A ^a   Abbott, Gina ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Coronary heart disease; Depression; Endothelial function; Measurement; Postmenopausal; Women

Indexed keywords

ADULT; AGED; ARTERY DILATATION; ARTICLE; CARDIOVASCULAR DISEASE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ARTICLE; FEMALE; FLOW MEDIATED DILATATION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL; STRUCTURED INTERVIEW; VASCULAR ENDOTHELIUM;

EID: 33744470572     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000195868.68122.9e     Document Type: Article

References (68)

1. Wenger N. Coronary heart disease: an older woman's major health risk. BMJ 1997;80:66H-8.
2. Wenger N, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1993;329:247-56.
3. Meihlan E. Sex steroid hormonal influences on coronary artery disease. In: Ness R, Kuller L, eds. Health and Disease among Women: Biological and Environmental Influences. New York: Oxford University Press; 1999:155-82.
4. Lett H, Blumenthal J, Babyak M, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-15.
5. Kessler R, McGonagle K, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Arch Gen Psychiatry 1994;51:8-19.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
7. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women: the women's health initiative (WHI). Arch Int Med 2004;164:289-98.
8. Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis 2004;46:337-47.
9. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004;161:271-7.
10. Ford D, Erlinger T. Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch Intern Med 2004;164:1010-4.
11. Tuglu C, Kara S, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003;170:429-33.
12. Penninx B, Beekman A, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221-7.
13. Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H. Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63:93-102.
14. Licinio J, Wong M. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999;4:317-27.
15. Chrapko WE, Jurasz P, Radomski MW, Lara N, Archer SL, Le Melledo JM. Decreased platelet nitric oxide synthase activity and plasma nitrate oxide metabolites in major depressive disorder. Biol Psychiatry 2004;56:129-34.
16. Damier M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003;65:347-56.
17. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychobiological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med 2001;63:531-44.
18. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196-8.
19. Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart 2002;88:521-3.
20. Harris KF, Matthews KA, Sutton-Tyrrell K, Kuller LH. Associations between psychological traits and endothelial function in postmenopausal women. Psychosom Med 2004;65:402-9.
21. Post R. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010.
22. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically health women with recurrent major depressive depression. J Neurosci 1999;19:5034-43.
23. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1999;58:99-110.
24. Bromberger JT, Kravitz HM, Wei HL, Brown C, Youk AO, Cordal A, Powell LH, Matthews KA. History of depression and women's current health and functioning during midlife. Gen Hosp Psychiatry 2005;27:200-8.
25. Agatisa PK, Matthews KA, Bromberger JT, Edmudowicz D, Change YF, Sutton-Tyrrell K. Coronary and aortic calcification in women with a history of major depression. Arch Intern Med 2005;165:1229-36.
26. Jones DJ, Bromberger JT, Sutton-Tyrrell K, Matthews KA. Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry 2003;60:153-60.
27. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229-33.
28. Esen AM, Barutcu I, Acar M, Degirmenci B, Kaya D, Turkmen M, Melek M, Onrat E, Esen OB, Kirma C. Effect of smoking on endothelial function and wall thickness of brachial artery. Circ J 2004;68:1123-6.
29. Rossi R, Cioni E, Nuzzo A, Origliani G, Modena MG. Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women. Diabetes Care 2005;28:702-7.
30. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults. National Institutes of Health; 2001. NIH Publication 01-3670.
31. Piche M, Weisnagel S, Nadeau A, Corneau L, Bergeron J, Lenieux S. Comparison of two proposed definitions of the metabolic syndrome in postmenopausal women not receiving hormonal replacement therapy (abstract). Diabetes 2004;750-P:A185.
32. Kannel W, Sorlie P. Framingham physical activity index. In: Pereira MA, Fitzgerald SJ, Gregg EW, Joswiak ML, Ryan WJ, Suminski RR, Utter AC, Zmuda JM, eds. A collection of physical activity questionnaires for health-related research. Med Sci Sports Exercise Supp 1997;29:S33-5.
33. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1977;1:385-401.
34. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10:77-84.
35. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-14.
36. First MB, Spitzer RL, Gibbon R, Williams JBW. Structured Clinical Interview from DSM-IV, Axis Disorders, Patient Edition (SCID-I/P Version 2.0, 8/98 revision). New York: New York State Psychiatric Institute; 1998.
37. Fleiss J. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley; 1981.
38. Skre I. High interrater reliability for the Structured Clinical Interview for DSM Axis 1. Acta Psychiatr Scan 1991;84:167-73.
39. Sobell L, Sobell M. Alcohol Timeline Followback User's Manual. Toronto: Addiction Research Foundation; 1995.
40. Project MATCH Research Group. Rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res 1993;17:1130-45.
41. Midanik LT, Hines AM, Barrett DC, Paul JP, Crosby GM, Stall RD. Self-reports of alcohol use, drug use and sexual behavior: expanding the timeline follow-back technique. J Stud Alcohol 1998;59:681-9.
42. Crosby GM, Stall RD, Paul JP, Barrett DC, Midanik LT. Condom use among gay/bisexual male substance abusers using the timeline follow-back method. Addict Behav 1996;21:249-57.
43. Bardone AM, Krahn DD, Goodman BM, Searles JS. Using interactive voice response technology and timeline follow-back methodology in studying binge eating and drinking behavior: different answers to different forms of the same question? Addict Behav 2000;25:1-11.
44. Weinstock J, Whelan JP, Meyers AW. Behavioral assessment of gambling: an application of the timeline follow-back method. Psychol Assess 2004;16:72-80.
45. Stephens RS, Babor TF, Kadden R, Miller M, Marijuana Treatment Project Research Group. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 2002;97:109-24.
46. Hersh D, Mulgrew C, Van Kirk J, Kranzler H. The validity of self-reported cocaine use in two groups of cocaine abusers. J Consult Clin Psychol 1999;67:37-42.
47. Sobell LC. Alcohol Timeline Followback (TLFB) [National Institute on Alcohol Abuse and Alcoholism (NIAAA) Web site]. Available at: http://www.niaaa.nui.gov/publications/Assesing%20Alcohol/InstrumentPDFs/13_TLFB. pdf. Accessed June 29, 2005.
48. Vinson D, Reidinger C, Wilcosky T. Factors affecting the validity of a timeline follow back interview. J Stud Alcohol 2003;64:733-40.
49. rd ed. New York: Harper Collins College Publishers; 1996.
50. Costa PT, McCrae RR. NEO PI-R Professional Manual: Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). Odessa, FL: Psychological Assessment Resources, Inc; 1992.
51. Scandell DJ. Development and initial validation of validity scales for the NEO-Five Factor Inventory. Pers Individ Dif 2000;29:1153-62.
52. Tokar DM, Fischer AR, Snell AF, Harik-Williams N. Efficient assessment of the five-factor model of personality: structural validity analyses of the NEO Five-Factor Inventory (Form S). Measure Eval Counsel Dev 1999;32:14-30.
53. Loehr LR, Espeland MA, Sutton-Tyrrell K, Burke GL, Crouse JR 3rd, Herrington DM. Racial differences in endotlielial function in postmenopausal women. Am Heart J 2004;148:606-11.
54. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65.
55. Gokce N, Keaney JF, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003;41:1769-75.
56. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch FR. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in health nonsmoking and smoking men. J Am Coll Cardiol 2001;38:1313-9.
57. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037-43.
58. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003;108:2093-8.
59. Kennedy N, Paykel ES. Residual symptoms at remission from depression: impact on long term outcome. J Affect Disord 2004;80:135-44.
60. Fawcett J. Antidepressants: partial response in chronic depression. Br J Psychiatry Suppl 1994;26:37-41.
61. Bothwell R, Scott J. The influence of cognitive variables on recovery in depressed inpatients. J Affect Disord 1997;43:207-12.
62. Rowan PJ, Haas D, Campbell JA, Maclean DR, Davidson KW. Depressive symptoms have an independent, gradient risk for coronary heart disease incidence in a random, population-based sample. Ann Epidemiol 2005;15:316-320.
63. Segal ZV, Williams JM, Teasdale JD, Gemar M. A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol Med 1996;26:371-80.
64. Kendler K, Thornton L, Gardener C. Stressful life event and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry 2000;157:1243-51.
65. Kendler K, Thornton L, Gardner C. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001;158:582-6.
66. Bijl RV, De Graaf R, Ravelli A, Smit F, Vollebergh WA. Netherlands Mental Health Survey and Incidence Study: gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Soc Psychiatry Psychiatr Epidemiol 2002;37:372-9.
67. Blaney P. Affect and memory: a review. Psychol Bull 1986;99:229-46.
68. Bower G. Mood and memory. Am Psychol 1981;36:129-48.